BACKGROUND: Recently, a functionally defective CHEK2 variant I157T has been proposed to associate with an increased risk of several types of cancer. We investigated the CHEK2 I157T variant for colorectal cancer (CRC) predisposition in a large population based study including a significant number of familial CRC cases. METHODS: We screened the CHEK2 I157T variant in a population based series of 1042 Finnish CRC patients using restriction fragment length polymorphism. Mutation status was studied for correlation with clinical characteristics and family history of CRC and other cancers. RESULTS: The frequency of CHEK2 I157T was significantly higher in CRC patients (7.8%, 76/972) than in healthy population controls (5.3%, 100/1885) (OR = 1.5, 95% CI 1.1 to 2.1, p = 0.008). The significant association of CHEK2 I157T with CRC was observed among patients with (10.4%, 14/135) and without (7.4%, 62/837) a family history of CRC (OR = 2.1, 95% CI 1.1 to 3.7, p = 0.01; OR = 1.4, 95% CI 1.0 to 2.0, p = 0.03; respectively). A trend towards higher variant frequency was also noted among patients with multiple primary tumours and a family history of any cancer. CONCLUSIONS: CHEK2 I157T associates with an increased risk of CRC: the association was observed both among familial and sporadic CRC patients. Furthermore, the higher frequency of I157T among patients with multiple primary tumours as well as those with a family history of any cancer supports a role for CHEK2 I157T as a susceptibility allele for multiple cancer types.
BACKGROUND: Recently, a functionally defective CHEK2 variant I157T has been proposed to associate with an increased risk of several types of cancer. We investigated the CHEK2I157T variant for colorectal cancer (CRC) predisposition in a large population based study including a significant number of familial CRC cases. METHODS: We screened the CHEK2I157T variant in a population based series of 1042 Finnish CRC patients using restriction fragment length polymorphism. Mutation status was studied for correlation with clinical characteristics and family history of CRC and other cancers. RESULTS: The frequency of CHEK2I157T was significantly higher in CRC patients (7.8%, 76/972) than in healthy population controls (5.3%, 100/1885) (OR = 1.5, 95% CI 1.1 to 2.1, p = 0.008). The significant association of CHEK2I157T with CRC was observed among patients with (10.4%, 14/135) and without (7.4%, 62/837) a family history of CRC (OR = 2.1, 95% CI 1.1 to 3.7, p = 0.01; OR = 1.4, 95% CI 1.0 to 2.0, p = 0.03; respectively). A trend towards higher variant frequency was also noted among patients with multiple primary tumours and a family history of any cancer. CONCLUSIONS:CHEK2I157T associates with an increased risk of CRC: the association was observed both among familial and sporadic CRC patients. Furthermore, the higher frequency of I157T among patients with multiple primary tumours as well as those with a family history of any cancer supports a role for CHEK2I157T as a susceptibility allele for multiple cancer types.
Authors: Natalia Bogdanova; Natalia Enssen-Dubrowinskaja; Sergei Feshchenko; Gennady I Lazjuk; Yuri I Rogov; Olaf Dammann; Michael Bremer; Johann H Karstens; Christof Sohn; Thilo Dörk Journal: Int J Cancer Date: 2005-08-20 Impact factor: 7.396
Authors: R Salovaara; A Loukola; P Kristo; H Kääriäinen; H Ahtola; M Eskelinen; N Härkönen; R Julkunen; E Kangas; S Ojala; J Tulikoura; E Valkamo; H Järvinen; J P Mecklin; L A Aaltonen; A de la Chapelle Journal: J Clin Oncol Date: 2000-06 Impact factor: 44.544
Authors: L A Aaltonen; R Salovaara; P Kristo; F Canzian; A Hemminki; P Peltomäki; R B Chadwick; H Kääriäinen; M Eskelinen; H Järvinen; J P Mecklin; A de la Chapelle Journal: N Engl J Med Date: 1998-05-21 Impact factor: 91.245
Authors: Mirjam M de Jong; Ilja M Nolte; Gerard J Te Meerman; Winette T A van der Graaf; Marcel J Mulder; Gerrit van der Steege; Marcel Bruinenberg; Michael Schaapveld; Renée C Niessen; Maran J W Berends; Rolf H Sijmons; Robert M W Hofstra; Elisabeth G E de Vries; Jan H Kleibeuker Journal: Genes Chromosomes Cancer Date: 2005-08 Impact factor: 5.006
Authors: C Cybulski; B Górski; T Huzarski; B Masojć; M Mierzejewski; T Debniak; U Teodorczyk; T Byrski; J Gronwald; J Matyjasik; E Zlowocka; M Lenner; E Grabowska; K Nej; J Castaneda; K Medrek; A Szymańska; J Szymańska; G Kurzawski; J Suchy; O Oszurek; A Witek; S A Narod; J Lubiński Journal: Am J Hum Genet Date: 2004-10-18 Impact factor: 11.025
Authors: Cezary Cybulski; Tomasz Huzarski; Bohdan Górski; Bartłomiej Masojć; Marek Mierzejewski; Tadeusz Debniak; Bartłomiej Gliniewicz; Joanna Matyjasik; Elzbieta Złowocka; Grzegorz Kurzawski; Andrzej Sikorski; Michał Posmyk; Marek Szwiec; Ryszard Czajka; Steven A Narod; Jan Lubiński Journal: Cancer Res Date: 2004-04-15 Impact factor: 12.701
Authors: Outi Kilpivaara; Pia Vahteristo; Jacob Falck; Kirsi Syrjäkoski; Hannaleena Eerola; Douglas Easton; Jirina Bartkova; Jiri Lukas; Päivi Heikkilä; Kristiina Aittomäki; Kaija Holli; Carl Blomqvist; Olli-Pekka Kallioniemi; Jiri Bartek; Heli Nevanlinna Journal: Int J Cancer Date: 2004-09-10 Impact factor: 7.396
Authors: Michael R Dufault; Beate Betz; Barbara Wappenschmidt; Wera Hofmann; Katrin Bandick; Astrid Golla; Andrea Pietschmann; Caroline Nestle-Krämling; Kerstin Rhiem; Christine Hüttner; Celia von Lindern; Peter Dall; Marion Kiechle; Michael Untch; Walter Jonat; Alfons Meindl; Siegfried Scherneck; Dieter Niederacher; Rita K Schmutzler; Norbert Arnold Journal: Int J Cancer Date: 2004-06-20 Impact factor: 7.396
Authors: Shuguang Leng; Christine A Stidley; Randy Willink; Amanda Bernauer; Kieu Do; Maria A Picchi; Xin Sheng; Melissa A Frasco; David Van Den Berg; Frank D Gilliland; Christopher Zima; Richard E Crowell; Steven A Belinsky Journal: Cancer Res Date: 2008-04-15 Impact factor: 12.701
Authors: Urszula Teodorczyk; Cezary Cybulski; Dominika Wokołorczyk; Anna Jakubowska; Teresa Starzyńska; Małgorzata Lawniczak; Paweł Domagała; Katarzyna Ferenc; Krzysztof Marlicz; Zbigniew Banaszkiewicz; Rafał Wiśniowski; Steven A Narod; Jan Lubiński Journal: Fam Cancer Date: 2013-09 Impact factor: 2.375
Authors: Sanna Siltanen; Kirsi Syrjäkoski; Rainer Fagerholm; Tarja Ikonen; Peter Lipman; Jacob Mallott; Kaija Holli; Teuvo L J Tammela; Heikki J Järvinen; Jukka-Pekka Mecklin; Kristiina Aittomäki; Carl Blomqvist; Joan E Bailey-Wilson; Heli Nevanlinna; Lauri A Aaltonen; Johanna Schleutker; Pia Vahteristo Journal: Eur J Hum Genet Date: 2008-03-12 Impact factor: 4.246
Authors: Anna Wójcicka; Małgorzata Czetwertyńska; Michał Świerniak; Joanna Długosińska; Monika Maciąg; Agnieszka Czajka; Kinga Dymecka; Anna Kubiak; Adam Kot; Rafał Płoski; Albert de la Chapelle; Krystian Jażdżewski Journal: Genes Chromosomes Cancer Date: 2014-03-06 Impact factor: 5.006